|
Forticell Bioscience, Incorporation - Company Profile Snapshot
| Company Profile: |
Forticell Bioscience, Incorporation |
| Ticker: |
FORBQ |
| Exchanges: |
OTC |
| 2007 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
20 |
Business Description
Forticell Bioscience, Incorporation Formerly known as Ortec International, Inc.. The Group's principal activity is to conduct research and development of tissue engineered skin regeneration product, for use in the treatment of chronic and acute wounds. The Group has developed a proprietary and patented technology known as OrCel, which is used to stimulate the repair and regeneration of human skin. OrCel is a two layered tissue engineered dressing that consists of human derived skin cells, both dermal and epidermal, supported within a porous collagen matrix. The composite matrix is seeded with keratinocytes for epidermal growth and fibroblasts for dermal growth. The Group also conducts a pivotal clinical trial for the use of OrCel in its cryopreserved form for the treatment of venous leg stasis and diabetic foot ulcers. The Group operates predominantly in the domestic market.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
